Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Antidiuretic Hormone (ADH) Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Antidiuretic Hormone (ADH) Market Status and Forecast (2016-2027)
      • 1.3.2 Global Antidiuretic Hormone (ADH) Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Antidiuretic Hormone (ADH) Supply by Company

    • 2.1 Global Antidiuretic Hormone (ADH) Sales Volume by Company
    • 2.2 Global Antidiuretic Hormone (ADH) Sales Value by Company
    • 2.3 Global Antidiuretic Hormone (ADH) Price by Company
    • 2.4 Antidiuretic Hormone (ADH) Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Antidiuretic Hormone (ADH) Market Status by Category

    • 3.1 Antidiuretic Hormone (ADH) Category Introduction
      • 3.1.1 Intravenous Injection
      • 3.1.2 Intramuscular Injection
      • 3.1.3 Subcutaneous Injection
    • 3.2 Global Antidiuretic Hormone (ADH) Market by Category
      • 3.2.1 Global Antidiuretic Hormone (ADH) Sales Volume by Category (2016-2021)
      • 3.2.2 Global Antidiuretic Hormone (ADH) Sales Value by Category (2016-2021)
      • 3.2.3 Global Antidiuretic Hormone (ADH) Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Antidiuretic Hormone (ADH) Market Status by End User/Segment

    • 4.1 Antidiuretic Hormone (ADH) Segment by End User/Segment
      • 4.1.1 Anti-Diuretic Hormone Deficiency
      • 4.1.2 Vasodilatory Shock
      • 4.1.3 Gastrointestinal Bleeding
      • 4.1.4 Ventricular Tachycardia & Fibrillation
    • 4.2 Global Antidiuretic Hormone (ADH) Market by End User/Segment
      • 4.2.1 Global Antidiuretic Hormone (ADH) Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Antidiuretic Hormone (ADH) Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Antidiuretic Hormone (ADH) Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Antidiuretic Hormone (ADH) Market Status by Region

    • 5.1 Global Antidiuretic Hormone (ADH) Market by Region
      • 5.1.1 Global Antidiuretic Hormone (ADH) Sales Volume by Region
      • 5.1.2 Global Antidiuretic Hormone (ADH) Sales Value by Region
    • 5.2 North America Antidiuretic Hormone (ADH) Market Status
    • 5.3 Europe Antidiuretic Hormone (ADH) Market Status
    • 5.4 Asia Pacific Antidiuretic Hormone (ADH) Market Status
    • 5.5 Central & South America Antidiuretic Hormone (ADH) Market Status
    • 5.6 Middle East & Africa Antidiuretic Hormone (ADH) Market Status

    6 North America Antidiuretic Hormone (ADH) Market Status

    • 6.1 North America Antidiuretic Hormone (ADH) Market by Country
      • 6.1.1 North America Antidiuretic Hormone (ADH) Sales Volume by Country (2016-2021)
      • 6.1.2 North America Antidiuretic Hormone (ADH) Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Antidiuretic Hormone (ADH) Market Status

    • 7.1 Europe Antidiuretic Hormone (ADH) Market by Country
      • 7.1.1 Europe Antidiuretic Hormone (ADH) Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Antidiuretic Hormone (ADH) Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Antidiuretic Hormone (ADH) Market Status

    • 8.1 Asia Pacific Antidiuretic Hormone (ADH) Market by Country
      • 8.1.1 Asia Pacific Antidiuretic Hormone (ADH) Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Antidiuretic Hormone (ADH) Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Antidiuretic Hormone (ADH) Market Status

    • 9.1 Central & South America Antidiuretic Hormone (ADH) Market by Country
      • 9.1.1 Central & South America Antidiuretic Hormone (ADH) Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Antidiuretic Hormone (ADH) Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Antidiuretic Hormone (ADH) Market Status

    • 10.1 Middle East & Africa Antidiuretic Hormone (ADH) Market by Country
      • 10.1.1 Middle East & Africa Antidiuretic Hormone (ADH) Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Antidiuretic Hormone (ADH) Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Antidiuretic Hormone (ADH) Manufacturing Cost Analysis
    • 11.5 Antidiuretic Hormone (ADH) Sales Channel and Distributors Analysis
      • 11.5.1 Antidiuretic Hormone (ADH) Sales Channel
      • 11.5.2 Antidiuretic Hormone (ADH) Distributors
    • 11.6 Antidiuretic Hormone (ADH) Downstream Major Buyers

    12 Global Antidiuretic Hormone (ADH) Market Forecast by Category and by End User/Segment

    • 12.1 Global Antidiuretic Hormone (ADH) Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Antidiuretic Hormone (ADH) Forecast by Category
      • 12.2.1 Global Antidiuretic Hormone (ADH) Sales Volume Forecast by Category
      • 12.2.2 Global Antidiuretic Hormone (ADH) Sales Value Forecast by Category
      • 12.2.3 Global Antidiuretic Hormone (ADH) Price Forecast by Category
    • 12.3 Global Antidiuretic Hormone (ADH) Forecast by End User/Segment
      • 12.3.1 Global Antidiuretic Hormone (ADH) Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Antidiuretic Hormone (ADH) Sales Value Forecast by End User/Segment
      • 12.3.3 Global Antidiuretic Hormone (ADH) Price Forecast by End User/Segment

    13 Global Antidiuretic Hormone (ADH) Market Forecast by Region/Country

    • 13.1 Global Antidiuretic Hormone (ADH) Market Forecast by Region (2022-2027)
      • 13.1.1 Global Antidiuretic Hormone (ADH) Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Antidiuretic Hormone (ADH) Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Shanghai Soho-Yiming Pharmaceuticals
      • 14.1.1 Company Information
      • 14.1.2 Antidiuretic Hormone (ADH) Product Introduction
      • 14.1.3 Shanghai Soho-Yiming Pharmaceuticals Antidiuretic Hormone (ADH) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Pfizer
      • 14.2.1 Company Information
      • 14.2.2 Antidiuretic Hormone (ADH) Product Introduction
      • 14.2.3 Pfizer Antidiuretic Hormone (ADH) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Par Pharmaceutical
      • 14.3.1 Company Information
      • 14.3.2 Antidiuretic Hormone (ADH) Product Introduction
      • 14.3.3 Par Pharmaceutical Antidiuretic Hormone (ADH) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Novartis
      • 14.4.1 Company Information
      • 14.4.2 Antidiuretic Hormone (ADH) Product Introduction
      • 14.4.3 Novartis Antidiuretic Hormone (ADH) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Fresenius Kabi
      • 14.5.1 Company Information
      • 14.5.2 Antidiuretic Hormone (ADH) Product Introduction
      • 14.5.3 Fresenius Kabi Antidiuretic Hormone (ADH) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Ferring Pharmaceuticals
      • 14.6.1 Company Information
      • 14.6.2 Antidiuretic Hormone (ADH) Product Introduction
      • 14.6.3 Ferring Pharmaceuticals Antidiuretic Hormone (ADH) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Astellas Pharma
      • 14.7.1 Company Information
      • 14.7.2 Antidiuretic Hormone (ADH) Product Introduction
      • 14.7.3 Astellas Pharma Antidiuretic Hormone (ADH) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Antidiuretic Hormone (ADH) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Antidiuretic Hormone (ADH) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

        Segmented by Category
        Intravenous Injection
        Intramuscular Injection
        Subcutaneous Injection

        Segmented by End User/Segment
        Anti-Diuretic Hormone Deficiency
        Vasodilatory Shock
        Gastrointestinal Bleeding
        Ventricular Tachycardia & Fibrillation

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        Shanghai Soho-Yiming Pharmaceuticals
        Pfizer
        Par Pharmaceutical
        Novartis
        Fresenius Kabi
        Ferring Pharmaceuticals
        Astellas Pharma

        Buy now